BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koch Hansen L, Sevelsted-Møller L, Rabjerg M, Larsen D, Hansen TP, Klinge L, Wulff H, Knudsen T, Kjeldsen J, Köhler R. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. J Crohns Colitis 2014;8:1378-91. [PMID: 24793818 DOI: 10.1016/j.crohns.2014.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Lintermans LL, Stegeman CA, Heeringa P, Abdulahad WH. T cells in vascular inflammatory diseases. Front Immunol. 2014;5:504. [PMID: 25352848 DOI: 10.3389/fimmu.2014.00504] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
2 Phan HTL, Kim HJ, Jo S, Kim WK, Namkung W, Nam JH. Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K+ Channels in T-Lymphocytes. Int J Mol Sci 2021;22:10847. [PMID: 34639190 DOI: 10.3390/ijms221910847] [Reference Citation Analysis]
3 Orbán C, Szabó D, Bajnok A, Vásárhelyi B, Tulassay T, Arató A, Veres G, Toldi G. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns. Oncotarget 2016;7:44966-74. [PMID: 27329601 DOI: 10.18632/oncotarget.10036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Thangaraj SS, Thiesson HC, Svenningsen P, Stubbe J, Palarasah Y, Bistrup C, Jensen BL, Mortensen LA. Mineralocorticoid receptor blockade with spironolactone has no direct effect on plasma IL-17A and injury markers in urine from kidney transplant patients. Am J Physiol Renal Physiol 2021. [PMID: 34894724 DOI: 10.1152/ajprenal.00104.2021] [Reference Citation Analysis]
5 Kazama I, Tamada T. Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs. Allergy Asthma Clin Immunol 2016;12:60. [PMID: 27956907 DOI: 10.1186/s13223-016-0168-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Thangaraj SS, Oxlund CS, Fonseca MPD, Svenningsen P, Stubbe J, Palarasah Y, Ketelhuth DFJ, Jacobsen IA, Jensen BL. The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension. J Hypertens 2022;40:153-62. [PMID: 34843183 DOI: 10.1097/HJH.0000000000002990] [Reference Citation Analysis]
7 Nguyen HM, Grössinger EM, Horiuchi M, Davis KW, Jin LW, Maezawa I, Wulff H. Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia. Glia 2017;65:106-21. [PMID: 27696527 DOI: 10.1002/glia.23078] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
8 Kacik M, Oliván-Viguera A, Köhler R. Modulation of K(Ca)3.1 channels by eicosanoids, omega-3 fatty acids, and molecular determinants. PLoS One 2014;9:e112081. [PMID: 25372486 DOI: 10.1371/journal.pone.0112081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
9 Foo NP, Liu YF, Wu PC, Hsing CH, Huang BM, So EC. Midazolam's Effects on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-lymphocytes. Int J Mol Sci 2021;22:7198. [PMID: 34281255 DOI: 10.3390/ijms22137198] [Reference Citation Analysis]
10 Maden SF, Acuner SE. Mapping Transcriptome Data to Protein-Protein Interaction Networks of Inflammatory Bowel Diseases Reveals Disease-Specific Subnetworks. Front Genet 2021;12:688447. [PMID: 34484291 DOI: 10.3389/fgene.2021.688447] [Reference Citation Analysis]
11 Pérez-verdaguer M, Capera J, Serrano-novillo C, Estadella I, Sastre D, Felipe A. The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies. Expert Opinion on Therapeutic Targets 2016;20:577-91. [DOI: 10.1517/14728222.2016.1112792] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
12 Kazama I. Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease. Medical Hypotheses 2015;85:61-3. [DOI: 10.1016/j.mehy.2015.03.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 Norton RS, Chandy KG. Venom-derived peptide inhibitors of voltage-gated potassium channels. Neuropharmacology 2017;127:124-38. [PMID: 28689025 DOI: 10.1016/j.neuropharm.2017.07.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
14 Orbán C, Szabó D, Bajnok A, Vásárhelyi B, Tulassay T, Arató A, Veres G, Toldi G. Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease. Immunol Lett 2017;185:48-51. [PMID: 28300604 DOI: 10.1016/j.imlet.2017.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 Jiang Y, Piao J, Liu N, Hou J, Liu J, Hu W. Effect of Ultrafine Powderization and Solid Dispersion Formation via Hot-Melt Extrusion on Antioxidant, Anti-Inflammatory, and the Human Kv1.3 Channel Inhibitory Activities of Angelica gigas Nakai. Bioinorg Chem Appl 2020;2020:7846176. [PMID: 32952541 DOI: 10.1155/2020/7846176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu H, Yang X, Yang J, Yuan Y, Wang Y, Zhang R, Xiong H, Xu Y. IL-17 Inhibits Oligodendrocyte Progenitor Cell Proliferation and Differentiation by Increasing K+ Channel Kv1.3. Front Cell Neurosci 2021;15:679413. [PMID: 34239419 DOI: 10.3389/fncel.2021.679413] [Reference Citation Analysis]
17 Zöphel D, Hof C, Lis A. Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels. Int J Mol Sci 2020;22:E110. [PMID: 33374304 DOI: 10.3390/ijms22010110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Unterweger AL, Jensen MØ, Giordanetto F, Jogini V, Rüschher A, Seuß M, Winkelmann P, Koletzko L, Shaw DE, Siebeck M, Gropp R, Beigel F, Aszodi A. Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis. J Crohns Colitis 2021:jjab078. [PMID: 33891001 DOI: 10.1093/ecco-jcc/jjab078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Tanner MR, Tajhya RB, Huq R, Gehrmann EJ, Rodarte KE, Atik MA, Norton RS, Pennington MW, Beeton C. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Clin Immunol 2017;180:45-57. [PMID: 28389388 DOI: 10.1016/j.clim.2017.03.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
20 Valero MS, Ramón-Gimenez M, Lozano-Gerona J, Delgado-Wicke P, Calmarza P, Oliván-Viguera A, López V, Garcia-Otín ÁL, Valero S, Pueyo E, Hamilton KL, Miura H, Köhler R. KCa3.1 Transgene Induction in Murine Intestinal Epithelium Causes Duodenal Chyme Accumulation and Impairs Duodenal Contractility. Int J Mol Sci 2019;20:E1193. [PMID: 30857243 DOI: 10.3390/ijms20051193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
21 Magalhães D, Cabral JM, Soares-da-Silva P, Magro F. Role of epithelial ion transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2016;310:G460-76. [PMID: 26744474 DOI: 10.1152/ajpgi.00369.2015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
22 Tajti G, Wai DCC, Panyi G, Norton RS. The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides. Biochem Pharmacol 2020;181:114146. [PMID: 32653588 DOI: 10.1016/j.bcp.2020.114146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
23 Chang SC, Huq R, Chhabra S, Beeton C, Pennington MW, Smith BJ, Norton RS. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3. FEBS J 2015;282:2247-59. [PMID: 25864722 DOI: 10.1111/febs.13294] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
24 Marie C, Verkerke HP, Theodorescu D, Petri WA. A whole-genome RNAi screen uncovers a novel role for human potassium channels in cell killing by the parasite Entamoeba histolytica. Sci Rep 2015;5:13613. [PMID: 26346926 DOI: 10.1038/srep13613] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
25 Chang WT, Liu PY, Wu SN. Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes. Molecules 2020;25:E4525. [PMID: 33023219 DOI: 10.3390/molecules25194525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Deng Z, Zhao Y, Ma Z, Zhang M, Wang H, Yi Z, Tuo B, Li T, Liu X. Pathophysiological role of ion channels and transporters in gastrointestinal mucosal diseases. Cell Mol Life Sci 2021;78:8109-25. [PMID: 34778915 DOI: 10.1007/s00018-021-04011-5] [Reference Citation Analysis]
27 Ye CJ, Li SA, Zhang Y, Lee WH. Geraniol targets KV1.3 ion channel and exhibits anti-inflammatory activity in vitro and in vivo. Fitoterapia 2019;139:104394. [PMID: 31669719 DOI: 10.1016/j.fitote.2019.104394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kim HJ, Park S, Shin HY, Nam YR, Lam Hong PT, Chin YW, Nam JH, Kim WK. Inhibitory effects of α-Mangostin on T cell cytokine secretion via ORAI1 calcium channel and K+ channels inhibition. PeerJ 2021;9:e10973. [PMID: 33717700 DOI: 10.7717/peerj.10973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Köhler R, Oliván-viguera A, Wulff H. Endothelial Small- and Intermediate-Conductance K Channels and Endothelium-Dependent Hyperpolarization as Drug Targets in Cardiovascular Disease. Endothelium. Elsevier; 2016. pp. 65-104. [DOI: 10.1016/bs.apha.2016.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
30 Gubič Š, Hendrickx LA, Toplak Ž, Sterle M, Peigneur S, Tomašič T, Pardo LA, Tytgat J, Zega A, Mašič LP. Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges. Med Res Rev 2021;41:2423-73. [PMID: 33932253 DOI: 10.1002/med.21800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Lozano-Gerona J, Oliván-Viguera A, Delgado-Wicke P, Singh V, Brown BM, Tapia-Casellas E, Pueyo E, Valero MS, Garcia-Otín ÁL, Giraldo P, Abarca-Lachen E, Surra JC, Osada J, Hamilton KL, Raychaudhuri SP, Marigil M, Juarranz Á, Wulff H, Miura H, Gilaberte Y, Köhler R. Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis. PLoS One 2020;15:e0222619. [PMID: 32150577 DOI: 10.1371/journal.pone.0222619] [Reference Citation Analysis]
32 Kazama I, Tamada T, Tachi M. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflamm Res 2015;64:753-65. [PMID: 26206235 DOI: 10.1007/s00011-015-0855-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
33 Pompeia C, Frare EO, Peigneur S, Tytgat J, da Silva ÁP, de Oliveira EB, Pereira A, Kerkis I, Kolonin MG. Synthetic polypeptide crotamine: characterization as a myotoxin and as a target of combinatorial peptides. J Mol Med (Berl) 2021. [PMID: 34643765 DOI: 10.1007/s00109-021-02140-9] [Reference Citation Analysis]